Head-to-head comparison of 11C-PiB and 18F-FC119S for Aβ imaging in healthy subjects, mild cognitive impairment patients, and Alzheimer's disease patients

被引:23
作者
Byun, Byung Hyun [1 ]
Kim, Byung Il [1 ]
Park, Su Yeon [2 ]
Ko, In Ok [3 ]
Lee, Kyo Chul [3 ]
Kim, Kyeong Min [3 ]
Kim, Yu Kyeong [4 ]
Lee, Jun-Young [5 ]
Bu, Seon Hee [6 ]
Kim, Jung Hwa [6 ]
Chi, Dae Yoon [7 ,8 ]
Ha, Jeong Ho [2 ]
Lim, Sang Moo [1 ]
机构
[1] Seoul Natl Univ, Dept Nucl Med, Seoul, South Korea
[2] Seoul Natl Univ, Korea Canc Ctr Hosp, Dept Neurol, Seoul, South Korea
[3] Seoul Natl Univ, Mol Imaging Res Ctr, Korea Inst Radiol & Med Sci, Seoul, South Korea
[4] Seoul Natl Univ, Dept Nucl Med, Seoul, South Korea
[5] Seoul Natl Univ, Boramae Hosp, Coll Med, Dept Psychiat & Behav Sci, Seoul, South Korea
[6] Seoul Bukbu Hosp, Dept Neurol, Seoul, South Korea
[7] FutureChem Co Ltd, Res Inst Labeling, Seoul, South Korea
[8] Sogang Univ, Dept Chem, Seoul, South Korea
关键词
Alzheimer's disease; beta amyloid (A beta); PET; PITTSBURGH COMPOUND-B; AMYLOID DEPOSITION; PET; FLORBETAPIR; F-18-FLORBETABEN; QUANTIFICATION;
D O I
10.1097/MD.0000000000006441
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
As a new beta amyloid (Ab) positron emission tomography (PET) tracer, F-18-FC119S has shown higher cortical uptake in patients with Alzheimer's disease (AD) than that in healthy control subjects without adverse effects in a previous preliminary study. The aim of this study was to compare F-18-FC119S PET and C-11-PiB PET in healthy control (HC) subjects, mild cognitive impairment (MCI) patients, and AD patients. A total of 48 subjects, including 28 HC subjects, 10 MCI patients, and 10 AD patients, underwent static F-18-FC119S PET (30 minutes after intravenous [i.v.] injection) and C-11-PiB PET (40 minutes after i. v. injection) on the same day. Both PET images were visually and quantitatively assessed. Standardized uptake value ratios (SUVRs) were calculated for each brain region using the cerebellar cortex as a reference region. None (0%) of the 28 HC subjects and 4 (40%) of 10 MCI patients had positive scans on both PET images. Of the 10 AD patients, 7 (70%) had positive scans on 11C-PiB PET while 6 (60%) had positive scans on F-18-FC119S PET. Overall, 47 (98%) of 48 participants showed identical results based on visual analysis. Cortical SUVR of F-18-FC119S was higher in AD patients (1.38 +/- 0.16), followed by that in MCI patients (1.24 +/- 0.10) and in HC subjects (1.14 +/- 0.05). Compared with C-11-PiB PET, F-18-FC119S PET yielded a higher effect size (d= 2.02 vs. 1.67) in AD patients and a slightly lower effect size (d= 1.26 vs. 1.38) in MCI patients. In HC subjects, the nonspecific binding of F-18-FC119S to white matter (with the frontal cortex-to-white matter SUV ratio of 0.76) was slightly lower than that of C-11-PiB ( ratio of 0.73). There was a significant linear correlation (slope= 0.41, r= 0.78, P< 0.001) between C-11-PiB and (18)FFC119S cortical SUVR. We could safely obtain images similar to C-11-PiB PET imaging Ab in the brain using F-18-FC119S PET. Therefore, F-18-FC119S might be suitable for imaging Ab deposition.
引用
收藏
页数:7
相关论文
共 31 条
  • [1] Automated PET-only quantification of amyloid deposition with adaptive template and empirically pre-defined ROI
    Akamatsu, G.
    Ikari, Y.
    Ohnishi, A.
    Nishida, H.
    Aita, K.
    Sasaki, M.
    Yamamoto, Y.
    Sasaki, M.
    Senda, M.
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 2016, 61 (15) : 5768 - 5780
  • [2] Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study
    Barthel, Henryk
    Gertz, Hermann-Josef
    Dresel, Stefan
    Peters, Oliver
    Bartenstein, Peter
    Buerger, Katharina
    Hiemeyer, Florian
    Wittemer-Rump, Sabine M.
    Seibyl, John
    Reininger, Cornelia
    Sabri, Osama
    [J]. LANCET NEUROLOGY, 2011, 10 (05) : 424 - 435
  • [3] Neuropathology of older persons without cognitive impairment from two community-based studies
    Bennett, D. A.
    Schneider, J. A.
    Arvanitakis, Z.
    Kelly, J. F.
    Aggarwal, N. T.
    Shah, R. C.
    Wilson, R. S.
    [J]. NEUROLOGY, 2006, 66 (12) : 1837 - 1844
  • [4] Byun BH, 2015, EUR J NUCL MED MO S1, V42, pS1
  • [5] Preclinical Properties of 18F-AV-45: A PET Agent for Aβ Plaques in the Brain
    Choi, Seok Rye
    Golding, Geoff
    Zhuang, Zhiping
    Zhang, Wei
    Lim, Nathaniel
    Hefti, Franz
    Benedum, Tyler E.
    Kilbourn, Michael R.
    Skovronsky, Daniel
    Kung, Hank F.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (11) : 1887 - 1894
  • [6] Use of Florbetapir-PET for Imaging β-Amyloid Pathology
    Clark, Christopher M.
    Schneider, Julie A.
    Bedell, Barry J.
    Beach, Thomas G.
    Bilker, Warren B.
    Mintun, Mark A.
    Pontecorvo, Michael J.
    Hefti, Franz
    Carpenter, Alan P.
    Flitter, Matthew L.
    Krautkramer, Michael J.
    Kung, Hank F.
    Coleman, R. Edward
    Doraiswamy, P. Murali
    Fleisher, Adam S.
    Sabbagh, Marwan N.
    Sadowsky, Carl H.
    Reiman, P. Eric M.
    Zehntner, Simone P.
    Skovronsky, Daniel M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (03): : 275 - 283
  • [7] MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN
    FOLSTEIN, MF
    FOLSTEIN, SE
    MCHUGH, PR
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) : 189 - 198
  • [8] [18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer's disease
    Hatashita, Shizuo
    Yamasaki, Hidetomo
    Suzuki, Yutaka
    Tanaka, Kumiko
    Wakebe, Daichi
    Hayakawa, Hideki
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (02) : 290 - 300
  • [9] Clinically Different Stages of Alzheimer's Disease Associated by Amyloid Deposition with [11C]-PIB PET Imaging
    Hatashita, Shizuo
    Yamasaki, Hidetomo
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2010, 21 (03) : 995 - 1003
  • [10] Quantitative Analysis of Amyloid Deposition in Alzheimer Disease Using PET and the Radiotracer 11C-AZD2184
    Ito, Hiroshi
    Shimada, Hitoshi
    Shinotoh, Hitoshi
    Takano, Harumasa
    Sasaki, Takeshi
    Nogami, Tsuyoshi
    Suzuki, Masayuki
    Nagashima, Tomohisa
    Takahata, Keisuke
    Seki, Chie
    Kodaka, Fumitoshi
    Eguchi, Yoko
    Fujiwara, Hironobu
    Kimura, Yasuyuki
    Hirano, Shigeki
    Ikoma, Yoko
    Higuchi, Makoto
    Kawamura, Kazunori
    Fukumura, Toshimitsu
    Boo, Eva Lindstrom
    Farde, Lars
    Suhara, Tetsuya
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (06) : 932 - 938